AstraZeneca drops $64.5 million buying Amgen plant

Drug company AstraZeneca purchased a biotech drug manufacturing plant on 228 acres in Longmont, spending $64.5 million buying the site from Amgen Inc. a year after purchasing another Amgen property in Boulder. AstraZeneca will use the Longmont plant in support of the Boulder drug manufacturing property, which AstraZeneca is renovating to produce its experimental bladder […]

teva pharmaceuticals

Teva completes $40 bn purchase of Allergan generics arm

Teva Pharmaceutical Tuesday completed its $40 billion acquisition of the generics arm of rival Allergan, a move the Israeli firm hailed as confirmation of its intention to become one of the world’s largest drugmakers. “Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan’s generics business (Actavis Generics)” […]

gsk GlaxoSmithKline

GlaxoSmithKline and Alphabet create $715 million bioelectronics firm

GlaxoSmithKline and Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics. Verily Life Sciences – known as Google’s life sciences unit until last year and Britain’s biggest drugmaker will together contribute 540 million pounds ($715.12 […]